Science of Modern Medicine
Since Descartes and the Renaissance, science, including medicine, has taken a distinct path in its analytical evaluation of the natural world. This approach can be described as one of “divide and conquer,” and it is rooted in the assumption that complex problems are solvable by dividing them into smaller, simpler, and thus more tractable units. Because the processes are “reduced” into more basic units, this approach has been termed “reductionism” and has been the predominant paradigm of science over the past two centuries. Reductionism pervades the medical sciences and affects the way we diagnose, treat, and prevent diseases. It has been responsible for tremendous successes in modern medicine and is generally referred as contemporary medicine.
While
the implementaton of clinical medicine is systems-oriented, the science of
clinical medicine is fundamentally reductionist. This is shown in four
prominent practices in medicine: (1) the focus on a singular, dominant factor,
(2) emphasis on homeostasis, (3) inexact risk modification, and (4) additive
treatments.
Focus on
a singular factor
When the
human body is viewed as a collection of components, the natural inclination of
medicine is to isolate the single factor that is most responsible for the
observed behavior. Much like a mechanic who repairs a broken car by locating
the defective part, physicians typically treat disease by identifying that
isolatable abnormality. Implicit within this practice is the deeply rooted
belief that each disease has a potential singular target for medical treatment.
For infection, the target is the pathogen; for cancer, it is the tumor; and for
gastrointestinal bleeding, it is the bleeding vessel or ulcer.
While
the success of this approach is undeniable, it leaves little room for
contextual information. A young immuno-compromised man with pneumococcal
pneumonia usually gets the same antibiotic treatment as an elderly woman with
the same infection. The disease, and not the person affected by it, becomes the
central focus. Our contemporary analytical tools are simply not designed to
address more complex questions, and, thus, questions such as “how do a person's
sleeping habits, diet, living condition, comorbidities, and stress collectively
contribute to his/her heart disease?” remain largely unanswered.
Emphasis
on homeostasis
For
decades, homeostasis has been a vital, guiding principle for medicine. Claude
Bernard in 1865 and later Walter B. Cannon popularized this principle,
expounding on the body's remarkable ability to maintain stability and constancy
in the face of stress. Since then, homeostasis has been incorporated into
clinical practice. Illness is defined as a failed homeostatic mechanism, and
treatment requires physicians to substitute for this failed mechanism by
correcting deviations and placing parameters within normal range. This
corrective treatment approach is true for a range of medical conditions, from
hypothyroidism to hypokalemia to diabetes.
This
interpretation of homeostasis, however, is biased by a reductionist viewpoint
in two ways. First, the emphasis on correcting the deviated parameter (e.g.,
low potassium) belies the importance of systemswide operations. Either
alternate, less intuitive targets may be more effective, or correction of the
deviated parameter may itself have harmful system-wide effects. Existing
evidence that demonstrates adverse effects of calcium for hypocalcemia or
blood pressure control for strokerelated hypertension points to the
limitations of this homeostasis interpretation as a universal principle.
Secondly,
the exclusive focus on normal ranges belies the importance of dynamic
stability. Because reductionism often disregards the dynamic interactions
between parts, the system is often depicted as a collection of static
components. Consequently, emphasis is placed on static stability/normal ranges
and not on dynamic stable states, such as oscillatory or chaotic (seemingly
random but deterministic) behavior. Circadian rhythms are an example of
oscillatory behavior, and complex heart rate variability is an example of
chaotic behavior. Failure to include these dynamic states in the homeostasis
model may lead to treatments that are either ineffective or even detrimental.
Inexact
risk modification
Since
disease cannot always be predicted with certainty, health professionals must
identify and modify risk factors. The common, unidimensional, “one-riskfactor
to one-disease” approach used in medical epidemiology, however, has certain
limitations.
An
example is hypertension, a known risk factor for coronary heart disease.
Guidelines suggest pharmacological and lifestyle treatment for individuals with
systolic blood pressure greater than 140. This strategy is supported by
evidence from the Framingham Study, which showed that men between 35 and 64
years of age with systolic blood pressures greater than 140 were twice as
likely to develop heart disease as compared to individuals with systolic blood
pressure less than 140. However, given that nearly 70% of the American
population is not affected by hypertension, up to 30% of coronary artery
disease develops in individuals with normal blood pressure. Conceivably, a
large number of people at small risk may give rise to more cases of disease
than a small number of people at high risk. This observation is termed the
prevention paradox.
To
capture these missed cardiac events, the natural recourse is to progressively
lower the blood pressure threshold for treatment. Consequently, the Joint
National Committee on Prevention, Detection, Evaluation, and Treatment of High
Blood Pressure lowered its initial diastolic blood pressure threshold of 105 in
1977 to 90 in 1980, to 85 (for high normal) in 1992, and to 80 (for
prehypertension) in 2003. The cost of such a strategy is the unnecessary
treatment of individuals who wouldn't have developed coronary disease in the
first place. This problem originates from the constraints imposed by a one-risk
to one-disease analysis and the inability to work with multiple risk factors and
calculate their collective influences. If a more multidimensional analytical
method were used, then more precise risk projections for individuals could be
devised.
Additive
treatments
In
reductionism, multiple problems in a system are typically tackled piecemeal.
Each problem is partitioned and addressed individually. In coronary artery
disease, for example, each known risk factor is addressed individually, whether
it be hyperlipidemia or hypertension. The strategy is also extended to
coexisting diseases, such as hypothyroidism, diabetes, and coronary artery
disease. Each disease is treated individually, as if the treatment of one
disorder (such as coronary artery disease) has minimal effects on the treatment
of another (such as hypothyroidism). While this approach is easily executable
in clinical practice, it neglects the complex interplay between disease and
treatment. The assumption is that the results of treatments are additive rather
than nonlinear.
*This
article is adapted from Andrew Ahn's paper: The Limits of Reductionism in
Medicine: Could Systems Biology Offer an Alternative?